Conversely, sustained plasma FFA reduction with acipimox in NGT subjects with strong family history of T2DM and in obese NGT and T2DM subjects enhances insulin-mediated muscle glucose disposal and suppression of hepatic glucose production [12, 13]. Here, INS is linked to type 2 diabetes mellitus.